That brings the total to 25 drugs that will have lower price tags, which account for a third of Medicare spending on ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

Pfizer’s PFE stock has risen 5.6% in the past month ... driven by its key in-line products like Vyndaqel and Eliquis, new launches and newly acquired products from Seagen (December 2023).

The top 10 patented drugs getting expired in the coming years in the US, include Pembrolizumab, sold under the brand name Keytruda by Merck and Co., Eliquis ... a growth of 12.5 per cent in ...

The company offers medicines and vaccines in various therapeutic areas, including: Cardiovascular metabolic and women’s health under the Premarin family and Eliquis ... to $59.5 to $62.5 billion ...

The drug is co-marketed with Bristol-Myers and was responsible for 11.5% of Pfizer's total sales in 2023, or around 16% when focusing on the U.S. market. As Eliquis will lose its main patent ...

And although 5 months is not a very long time (at least ... When looking at the two blockbusters Eliquis increased 11% year-over-year growth to $3,002 million in quarterly sales and Revlimid ...